Basel university < Baseline < Baseline characteristics

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Baseline

Number of relevant bibliographic references: 74.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001188 (2013)	Fariz Yahya [Malaisie] ; Raja Jasmin [Malaisie] ; Chin Teck Ng [Malaisie] ; Tien Eang Cheah [Malaisie] ; Sargunan Sockalingam [Malaisie]	Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement
001249 (2013)		Abstracts
001400 (2012)	J. S. Wee [Royaume-Uni] ; P. J. Shirlaw [Royaume-Uni] ; S. J. Challacombe [Royaume-Uni] ; J. F. Setterfield [Royaume-Uni]	Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients
001411 (2012)	Sengwee Toh [États-Unis] ; Lingling Li [États-Unis] ; Leslie R. Harrold [États-Unis] ; Elizabeth A. Bayliss [États-Unis] ; Jeffrey R. Curtis [États-Unis] ; Liyan Liu [États-Unis] ; Lang Chen [États-Unis] ; Carlos G. Grijalva [États-Unis] ; Lisa J. Herrinton [États-Unis]	Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?
001441 (2012)	Larry W. Moreland [États-Unis] ; James R. O'Dell ; Harold E. Paulus ; Jeffrey R. Curtis ; Joan M. Bathon [États-Unis] ; E. William St. Clair [États-Unis] ; S. Louis Bridges Jr. ; Jie Zhang ; Theresa Mcvie ; George Howard ; Désirée Van Der Heijde [Pays-Bas] ; Stacey S. Cofield	A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
001482 (2011)	Naomi B. Klarenbeek [Pays-Bas] ; Melek Güler-Yüksel [Pays-Bas] ; Sjoerd M. Van Der Kooij [Pays-Bas] ; K Huub Han [Pays-Bas] ; H Karel Ronday [Pays-Bas] ; Pit J S M. Kerstens [Pays-Bas] ; Patrick E H. Seys [Pays-Bas] ; Tom W J. Huizinga [Pays-Bas] ; Ben A C. Dijkmans [Pays-Bas] ; Cornelia F. Allaart [Pays-Bas]	The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study
001577 (2011)		Bristol Cup Posters
001588 (2011)		ARA Scientific Posters
001753 (2010)		2.7. Systemic lupus erythematosus, Sjögren's and antiphospholipid syndrome ‐ clinical aspects, comorbidities and complications
001754 (2010)		2.3. Rheumatoid arthritis ‐ anti‐TNFα therapy
001779 (2009)	M. Schiff [États-Unis] ; C. Pritchard [États-Unis] ; J E Huffstutter [États-Unis] ; V. Rodriguez-Valverde [Espagne] ; P. Durez [Belgique] ; X. Zhou [États-Unis] ; T. Li [États-Unis] ; K. Bahrt [États-Unis] ; S. Kelly [États-Unis] ; M. Le Bars [France] ; M C Genovese [États-Unis]	The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
001873 (2009)	Ja Reynolds [Royaume-Uni] ; V. Toescu [Royaume-Uni] ; Cs Yee [Royaume-Uni] ; A. Prabu [Royaume-Uni] ; D. Situnayake [Royaume-Uni] ; C. Gordon [Royaume-Uni]	Effects of rituximab on resistant SLE disease including lung involvement
001972 (2008)	T Y-T Lu [Royaume-Uni] ; T. Jonsdottir [Suède] ; R F Van Vollenhoven [Suède] ; D A Isenberg [Royaume-Uni]	Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases
001A32 (2008)		Abstracts
001B88 (2007)	Gerd R. Burmester [Allemagne] ; Xavier Mariette [France] ; Carlomaurizio Montecucco [Italie] ; Indalecio Monteagudo-Sáez [Espagne] ; Michel Malaise [Belgique] ; Athanasios G. Tzioufas [Grèce] ; Johannes W J. Bijlsma [Pays-Bas] ; Kristina Unnebrink [Allemagne] ; Sonja Kary [Allemagne] ; Hartmut Kupper [Allemagne]	Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
001C33 (2006)		VASCULITIS
001C36 (2006)	Emil Bisaccia [États-Unis] ; Mark Palangio [États-Unis] ; Joselyn Gonzalez [États-Unis] ; Kenneth R. Adler [États-Unis] ; Richard Scarborough [États-Unis] ; Stuart L. Goldberg [États-Unis] ; Scott D. Rowley [États-Unis]	Treatment of extensive chronic graft‐versus‐host disease with extracorporeal photochemotherapy
001C63 (2006)		SYSTEMIC LUPUS ERYTHEMATOSUS – CLINICAL ASPECTS
001C64 (2006)		SYSTEMIC LUPUS ERYTHEMATOSUS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODELS
001C65 (2006)		SPONDYLOARTHROPATHIES INCLUDING PSORIATIC ARTHRITIS
001C66 (2006)		SJOGREN'S SYNDROME

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Baseline" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Baseline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Baseline
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021